Jennifer J Rhodes insider trades: Acadia Pharmaceuticals (ACAD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | ACAD | ↓ Sell | 6,950 | $23.38 | $162K | Direct | Feb 10, 2026 (1d) |
| Dec 14, 2021 | ANGN | ↓ Sell | 451 | $2.42 | $1K | Direct | Dec 15, 2021 (1d) |
| Nov 15, 2021 | ANGN | ↓ Sell | 433 | $4.40 | $2K | Direct | Nov 16, 2021 (1d) |
| Oct 14, 2021 | ANGN | ↓ Sell | 430 | $8.65 | $4K | Direct | Oct 15, 2021 (1d) |
| Sep 14, 2021 | ANGN | ↓ Sell | 430 | $10.64 | $5K | Direct | Sep 15, 2021 (1d) |
| Aug 16, 2021 | ANGN | ↓ Sell | 445 | $10.68 | $5K | Direct | Aug 17, 2021 (1d) |
| Jul 21, 2021 | ANGN | ↓ Sell | 432 | $10.94 | $5K | Direct | Jul 22, 2021 (1d) |
| Jul 14, 2021 | ANGN | ↓ Sell | 431 | $11.01 | $5K | Direct | Jul 15, 2021 (1d) |
| Jun 14, 2021 | ANGN | ↓ Sell | 427 | $13.27 | $6K | Direct | Jun 16, 2021 (2d) |
| May 14, 2021 | ANGN | ↓ Sell | 440 | $13.92 | $6K | Direct | May 18, 2021 (4d) |
| Apr 15, 2021 | ANGN | ↓ Sell | 399 | $15.01 | $6K | Direct | Apr 15, 2021 (0d) |
| Mar 13, 2021 | ANGN | ↓ Sell | 499 | $20.45 | $10K | Direct | Mar 16, 2021 (3d) |
| Feb 13, 2021 | ANGN | ↓ Sell | 457 | $19.54 | $9K | Direct | Feb 17, 2021 (4d) |
| Jun 20, 2019 | ADMS | ↓ Sell | 940 | $5.35 | $5K | Direct | Jun 21, 2019 (1d) |
| Mar 20, 2019 | ADMS | ↓ Sell | 1,792 | $7.99 | $14K | Direct | Mar 21, 2019 (1d) |
| Dec 20, 2018 | ADMS | ↓ Sell | 425 | $7.52 | $3K | Direct | Dec 21, 2018 (1d) |
| Jun 21, 2018 | ADMS | ↓ Sell | 1,002 | $25.48 | $26K | Direct | Jun 22, 2018 (1d) |
| Mar 21, 2018 | ADMS | ↓ Sell | 982 | $25.89 | $25K | Direct | Mar 22, 2018 (1d) |
| Dec 21, 2017 | ADMS | ↓ Sell | 440 | $32.30 | $14K | Direct | Dec 21, 2017 (0d) |
| Jun 21, 2017 | ADMS | ↓ Sell | 1,041 | $17.53 | $18K | Direct | Jun 22, 2017 (1d) |
| Mar 16, 2015 | MDVN | ↓ Sell | 1,390 | $130.92 | $182K | Direct | Mar 17, 2015 (1d) |
| Mar 2, 2015 | MDVN | ↓ Sell | 2,000 | $122.00 | $244K | Direct | Mar 2, 2015 (0d) |
| Feb 26, 2015 | MDVN | ↓ Sell | 3,089 | $119.29 | $369K | Direct | Feb 27, 2015 (1d) |
| Feb 4, 2015 | MDVN | ↓ Sell | 610 | $100.85 | $62K | Direct | Feb 6, 2015 (2d) |
| Dec 3, 2014 | MDVN | ↓ Sell | 910 | $113.00 | $103K | Direct | Dec 4, 2014 (1d) |
| Jan 21, 2014 | MDVN | ↓ Sell10b5-1 | 14,000 | $76.28 | $1.1M | Direct | Jan 23, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACAD insiders
Open-market trades in the last 12 months
About Jennifer J Rhodes's insider trades
Jennifer J Rhodes is EVP, Chief Legal Officer, Sec at Acadia Pharmaceuticals (ACAD). Since Jan 21, 2014, Jennifer has reported no open-market purchases and 26 sales worth $2.4M on SEC Form 4. In the last 12 months: 1 sale ($162K).
1 sale (45% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACAD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.